SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001253
Filing Date
2023-05-15
Accepted
2023-05-15 17:25:44
Documents
81
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230331x10q.htm   iXBRL 10-Q 1271371
2 EX-31.1 tmb-20230331xex31d1.htm EX-31.1 13090
3 EX-31.2 tmb-20230331xex31d2.htm EX-31.2 12983
4 EX-32 tmb-20230331xex32.htm EX-32 9971
  Complete submission text file 0001410578-23-001253.txt   6417883

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20230331.xsd EX-101.SCH 63544
6 EX-101.CAL tmb-20230331_cal.xml EX-101.CAL 48852
7 EX-101.DEF tmb-20230331_def.xml EX-101.DEF 143290
8 EX-101.LAB tmb-20230331_lab.xml EX-101.LAB 447464
9 EX-101.PRE tmb-20230331_pre.xml EX-101.PRE 319333
75 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230331x10q_htm.xml XML 1142121
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 23924511
SIC: 2834 Pharmaceutical Preparations